GT200100106A - CARBOXIALQUILETER COMBINATIONS - ACAT INHIBITOR. - Google Patents
CARBOXIALQUILETER COMBINATIONS - ACAT INHIBITOR.Info
- Publication number
- GT200100106A GT200100106A GT200100106A GT200100106A GT200100106A GT 200100106 A GT200100106 A GT 200100106A GT 200100106 A GT200100106 A GT 200100106A GT 200100106 A GT200100106 A GT 200100106A GT 200100106 A GT200100106 A GT 200100106A
- Authority
- GT
- Guatemala
- Prior art keywords
- carboxialquileter
- acat inhibitor
- combinations
- arteroscleroisis
- aciltransferiaid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN CARBOXIALQUILETER QUE REDUCE TRIGLICERIDOS Y LDL Y ELEVA HDL Y UN INHIBIDOR DE ACAT O MEJOR CONOCIDO COMO ACILCOENZIMA A : COLESTEROL ACILTRANSFERASA, QUE MEJORA LA DISLIPIDEMIA EN MAMIFEROS, DICHA COMPOSICION ES UTIL PARA TRATAR LA DISPLIPIDEMIA Y SINDROMES ISQUEMICOS Y PARA PREVENIR O RETARDAR EL COMIENZO DE ATAQUES CARDIACOS, ADEMAS SIRVE PARA TRATAR LA HIPERCOLESTEROLEMIA Y LA ARTEROSCLEROISIS.THE INVENTION CONCERNS A PHARMACEUTICAL COMPOSITION THAT INCLUDES A CARBOXIALQUILETER THAT REDUCES TRIGLICERIDES AND LDL AND ELEVATES HDL AND A ACAT INHIBITOR OR BETTER KNOWN AS ACILCOENZIMA A: COLESTEROL ACILTRANSFERIAID LABELS THEMSELVES, COMPOSED TO THREE AND ISCHEMICAL SYNDROMES AND TO PREVENT OR DELAY THE BEGINNING OF CARDIAC ATTACKS, WE ALSO SERVE TO TREAT HYPERCHOLESTEROLEMIA AND ARTEROSCLEROISIS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21005600P | 2000-06-07 | 2000-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200100106A true GT200100106A (en) | 2002-05-20 |
Family
ID=22781424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200100106A GT200100106A (en) | 2000-06-07 | 2001-06-05 | CARBOXIALQUILETER COMBINATIONS - ACAT INHIBITOR. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1292363A2 (en) |
JP (1) | JP2003535125A (en) |
AR (1) | AR034255A1 (en) |
AU (1) | AU2001263003A1 (en) |
BR (1) | BR0111428A (en) |
CA (1) | CA2413906A1 (en) |
GT (1) | GT200100106A (en) |
MX (1) | MXPA02010762A (en) |
PA (1) | PA8518601A1 (en) |
PE (1) | PE20020265A1 (en) |
SV (1) | SV2002000466A (en) |
TN (1) | TNSN01085A1 (en) |
UY (1) | UY26752A1 (en) |
WO (1) | WO2001093845A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7387236B2 (en) | 2001-10-09 | 2008-06-17 | Delaware Capital Formation, Inc. | Dispensing of currency |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002501887A (en) * | 1998-01-28 | 2002-01-22 | ワーナー−ランバート・カンパニー | How to treat Alzheimer's disease |
-
2001
- 2001-05-08 WO PCT/US2001/014804 patent/WO2001093845A2/en active Application Filing
- 2001-05-08 CA CA002413906A patent/CA2413906A1/en not_active Abandoned
- 2001-05-08 BR BR0111428-0A patent/BR0111428A/en not_active IP Right Cessation
- 2001-05-08 MX MXPA02010762A patent/MXPA02010762A/en not_active Application Discontinuation
- 2001-05-08 AU AU2001263003A patent/AU2001263003A1/en not_active Abandoned
- 2001-05-08 JP JP2002501418A patent/JP2003535125A/en active Pending
- 2001-05-08 EP EP01937250A patent/EP1292363A2/en not_active Withdrawn
- 2001-05-24 SV SV2001000466A patent/SV2002000466A/en not_active Application Discontinuation
- 2001-06-05 PE PE2001000517A patent/PE20020265A1/en not_active Application Discontinuation
- 2001-06-05 GT GT200100106A patent/GT200100106A/en unknown
- 2001-06-05 TN TNTNSN01085A patent/TNSN01085A1/en unknown
- 2001-06-05 UY UY26752A patent/UY26752A1/en not_active Application Discontinuation
- 2001-06-05 PA PA20018518601A patent/PA8518601A1/en unknown
- 2001-06-06 AR ARP010102688A patent/AR034255A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR034255A1 (en) | 2004-02-18 |
BR0111428A (en) | 2003-06-10 |
TNSN01085A1 (en) | 2005-11-10 |
WO2001093845A3 (en) | 2002-10-10 |
UY26752A1 (en) | 2001-07-31 |
WO2001093845A2 (en) | 2001-12-13 |
CA2413906A1 (en) | 2001-12-13 |
JP2003535125A (en) | 2003-11-25 |
EP1292363A2 (en) | 2003-03-19 |
MXPA02010762A (en) | 2003-03-10 |
PA8518601A1 (en) | 2002-07-30 |
SV2002000466A (en) | 2002-04-03 |
AU2001263003A1 (en) | 2001-12-17 |
PE20020265A1 (en) | 2002-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY26929A1 (en) | ANTIANGIOGEN POLIPEPTIDES AND METHODS TO INHIBIT THE ANGIOGENESIS | |
GT200500137A (en) | USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS. | |
PA8525301A1 (en) | THERAPEUTIC COMBINATION | |
PA8506101A1 (en) | USE OF AN ACAT COMPOUND TO MANUFACTURE A PHARMACEUTICAL COMPOSITION | |
GT200000158A (en) | PIRIDINES AND REPLACED PYRIDACINES WITH ANGIOGENESIS INHIBITION ACTIVITY. | |
GT200300053A (en) | COMPOUNDS THAT MODULATE THE ACTIVITY OF PPAR | |
AR022023A1 (en) | COMBINATIONS OF ILEO-BILIAR ACID TRANSPORTATION INHIBITORS WITH FIBRIC ACID DERIVATIVES FOR CARDIOVASCULAR PRESCRIPTIONS | |
CU23213A3 (en) | DIFENILUREAS REPLACED WITH OMEGA-CARBOXIARILO AS RAF QUINASA INHIBITORS | |
GT200300054A (en) | COMPOUNDS THAT MODULATE THE ACTIVITY OF PPAR | |
EA200300953A1 (en) | THERAPEUTIC COMBINATIONS FOR USE IN CARDIOVASCULAR AND INFLAMMATORY DISEASES | |
PA8513601A1 (en) | PHARMACEUTICAL COMPOSITIONS OF GLUCOGENOPHOSPHORILASE INHIBITORS | |
GT200000077A (en) | MUTUAL SALT OF AMLODIPINO AND ATORVASTATINA | |
MX2008001597A (en) | Novel formulations comprising fenofibrate and a statin, and related methods of treatment. | |
BR0213181A (en) | Cox-2 inhibitor combinations | |
ECSP003707A (en) | DIAZEPANES | |
PA8464601A1 (en) | COMBINATIONS OF STATIN-CARBOXYALKYL ETHER | |
AR054368A1 (en) | METHOD TO TREAT HYPERLIPIDEMIA | |
GT200100106A (en) | CARBOXIALQUILETER COMBINATIONS - ACAT INHIBITOR. | |
SV2004000109A (en) | COMBINATION OF MTP INHIBITORS AND INHIBITORS OF HMG-COA REDUCTASA AND ITS USE IN MEDICINES REF.LEA 33846-SV | |
PA8469001A1 (en) | MMP STATIN-INHIBITOR COMBINATIONS. | |
DOP2001000150A (en) | HYPERTENSIVE AGENT AND ITS USE | |
SV2002000639A (en) | PHENOXYPHENYL ALCANOSULFONATES REF. READ 34813-SV | |
PA8500101A1 (en) | COMPOSITIONS AND METHODS TO TREAT ALLERGIC AND INFLAMMATORY CONDITIONS WITH YOU | |
CY1115453T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN ANALYTICAL AGENT OF THE EMG-COAGA ENZYMING ENZYME AND AN ANALYTICAL EXTRACTIVE FACTOR | |
ECSP003368A (en) | METHOD FOR TREATING COPD |